ARKRAY USA, Inc., a leader in diabetes care products, announced today the US launch of the Assure® ID Safety Pen Needles. Safety pen needles are designed to protect healthcare professionals and their patients from unintended needlesticks during the injection of insulin.
The Assure ID Safety Pen Needles use a shield that automatically locks after injection, helping to prevent accidental needlesticks. With a broad shield diameter that reduces pressure on the patient’s skin, the Assure ID Safety Pen Needles are designed for smooth needle penetration, reducing discomfort for patients. They are also designed to be compatible with most major brands of injection pens on the market.
“The launch of the Assure ID Safety Pen Needles confirms ARKRAY’s commitment to bringing innovative and affordably priced diabetes products to the US healthcare market,” said ARKRAY USA President Jonathan Chapman. “Healthcare professionals and their patients with insulin-dependent diabetes will now have another option to safely deliver insulin injections.”
About ARKRAY USA, Inc.
ARKRAY USA, Inc. is a division of ARKRAY, a global leader in diabetes care with headquarters in Kyoto, Japan. For more than half a century, ARKRAY has pioneered products to ensure that people who have diabetes – and the health professionals who care for them – can better manage the condition. ARKRAY currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the U.S. The Company has a long history of developing cutting edge technology such as the first portable glucose analyzer available in the United States; the first HbA1C analyzer; and the first hand-held blood glucose meter. For more information, visit www.arkrayusa.com.
You must be logged in to post a comment.